Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine When Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients
Brief Summary: The purpose of this study is to determine if one drug is superior to another with regard to safety and the preservation of renal function after a kidney transplant.


Options:
A: Intervention Type: DRUG; Name: sirolimus; Assigned to Arm(s): N/A
B: Arm Label: Everolimus + Low dose CsA +PD; Type: EXPERIMENTAL; Interventions: Drug: Everolimus + Low dose CsA +PD | Arm Label: Myfortic+ Standard CsA + PD; Type: ACTIVE_COMPARATOR; Interventions: Drug: Myfortic+ Standard CsA + PD | Intervention Type: DRUG; Name: Everolimus + Low dose CsA +PD; Assigned to Arm(s): Everolimus + Low dose CsA +PD | Intervention Type: DRUG; Name: Myfortic+ Standard CsA + PD; Assigned to Arm(s): Myfortic+ Standard CsA + PD
C: Arm Label: Everolimus + Reduced dose of cyclosporine; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Basiliximab, Drug: Cyclosporine A, Drug: Corticosteroid | Arm Label: Mycophenolate mofetil (MMF) + Standard dose of cyclosporine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mycophenolate mofetil (MMF), Drug: Basiliximab, Drug: Cyclosporine A, Drug: Corticosteroid | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Everolimus + Reduced dose of cyclosporine | Intervention Type: DRUG; Name: Mycophenolate mofetil (MMF); Assigned to Arm(s): Mycophenolate mofetil (MMF) + Standard dose of cyclosporine | Intervention Type: DRUG; Name: Basiliximab; Assigned to Arm(s): Everolimus + Reduced dose of cyclosporine, Mycophenolate mofetil (MMF) + Standard dose of cyclosporine | Intervention Type: DRUG; Name: Cyclosporine A; Assigned to Arm(s): Everolimus + Reduced dose of cyclosporine, Mycophenolate mofetil (MMF) + Standard dose of cyclosporine | Intervention Type: DRUG; Name: Corticosteroid; Assigned to Arm(s): Everolimus + Reduced dose of cyclosporine, Mycophenolate mofetil (MMF) + Standard dose of cyclosporine
D: Arm Label: Thymoglobulin and everolimus; Type: EXPERIMENTAL; Interventions: Drug: Thymoglobulin, Drug: Everolimus, Drug: Tacrolimus | Arm Label: Basiliximabe and everolimus; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Basiliximabe, Drug: Tacrolimus | Arm Label: Basiliximabe and mycophenolate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Basiliximabe, Drug: mycophenolate sodium, Drug: Tacrolimus | Intervention Type: DRUG; Name: Thymoglobulin; Assigned to Arm(s): Thymoglobulin and everolimus | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Basiliximabe and everolimus, Thymoglobulin and everolimus | Intervention Type: DRUG; Name: Basiliximabe; Assigned to Arm(s): Basiliximabe and everolimus, Basiliximabe and mycophenolate | Intervention Type: DRUG; Name: mycophenolate sodium; Assigned to Arm(s): Basiliximabe and mycophenolate | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): Thymoglobulin and everolimus | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): Basiliximabe and everolimus | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): Basiliximabe and mycophenolate

Answer: A